PPARG and Hyperglycemia: It cannot be excluded that KATP channel blockers like repaglinide may affect oxidative/nitrosative stress but PPARγ agonists like pioglitazone seem to act more comprehensively which was confirmed independently on their action oh hyperglycemia.